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The first kidney transplant in Hawaii was performed in August 
1969. In the following 25 years, more than 433 kidney transplants 
were performed. The most common etiology leading to trans-
plantation was chronic glomerulonephritis. Patient and graft 
survivals after a kidney transplant have progressively improved, 
particularly after the introduction of cyclosporine in 1984. The 
overall one-year patient and graft survival rates now are 96% and 
85%, respectively; these results exceed the national averages. 
Introduction 
The first kidney transplant in Hawaii was performed in 
August 1969ona43-year-oldmanwithadiagnosisofmembra-
nous glomerulonephritis. Prior to the transplant, he had been 
maintained on hemodialysis for 17 months. The early efforts of 
Drs Livingston Wong, David Hume, Arnold Siemsen, and 
Herbert Y.H. Chinn brought about this surgical procedure; 
combined with excellent follow-up care provided by the 
nephrologists, the quality of life for many patients with end-
stage renal disease has improved. The growth and development 
of this new technology was crucial in Hawaii where geographic 
isolation might otherwise force many patients to travel to the 
Mainland for kidney transplantation or to remain on dialysis 
without surgery. 
The objectives of this study were to: 1. Examine St. Francis 
Medical Center's experience from a historical perspective; 
2. Compare the results with available national statistics; 3. Re-
view briefly the indications, techniques, and immunosuppres-
sion used in kidney transplantation. 
Methods 
Between August 1969 and December 1993, a total of 433 
kidney transplants were performed at St. Francis Medical Center 
in Honolulu. The approach to patient care, including recipient 
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and donor selection, timing of the transplant, surgical tech-
niques, immunosuppressive protocols, treatment of rejection, 
and ancillary care have been similar to those described in detail 
in the literature.1•2•3•4•5•6•7 Of these 433 transplants, 405 were 
available for analysis using the UCLA/United Network of 
Organ Sharing (UNOS) Scientific Registry. 
The UNOS Scientific Registry was created in October 1987 
following enactment of legislation contained in the Transplant 
Act of 1984 and records all kidney transplants performed in the 
United States. Prior to 1987, kidney transplantation registry data 
was maintained by Dr Terasaki at the UCLA Tissue Typing 
Laboratory. This retrospective review used the UNOS Kidney 
Transplant Registry data base and locally available charts at St. 
Francis Medical Center. 
Because of the number of study patients, data was stratified 
into historical periods: 
1. Erai-August 1969 to December 1983. This is referred to as 
the pre-cyclosporin A (Pre-CsA) period. Immunosuppression 
consisted of steroids and azathioprine. A total of 186 transplants 
were performed during this period. 
2. Eraii-January 1984toDecember 1989. The powerful new 
drug, cyclosporin A (CsA) was introduced and used on all 
transplant patients to prevent graft rejection, in addition to 
steroids and azathioprine. 0 KT3 also was available to treat acute 
rejections. A total of 13 7 transplants were performed during this 
time period. 
3. Era III-January 1990 to December 1992. A total of 89 
transplants were performed during this time period. The same 
immunosuppressive regimen as Era II was used. 
4. Era IV-January 1993 to December 1993. A total of 21 
transplants were done this past year. The same immunosuppres-
sive regimen as Era II and III was used. 
Patient and graft survival rates for each era were calculated by 
statistical analysis using the Kaplan-Meier method for estimat-
ing survival. Graft loss was defined as the earliest return to 
maintenance dialysis, retransplantation, or death and all causes 
of death were included in the analysis. 
Results 
The number of kidney transplants performed each year since 
the premier transplantation in 1969 and the source of donor 
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kidneys are shown (Fig 1). Only living-related donor (LRD) 
kidney transplants were performed in 1969 and 1970. Most of 
the donor organs carne from cadavers (CAD), with a total of344 
cadaver- versus 88living-related donor kidneys. The patients' 
ages ranged from 3.5 years to 70 years and 58% were men and 
42% were women. The majority of the patient population was 
Asian (Table 1). Most of these patients had ABO blood type A 
and were non-diabetic. Some of the common causes of renal 
failure for our population are listed (Table 2). 
The overall patient survival rates were stratified by era. Prior 
to 1984, prednisone and azathioprine, or conventional therapy 
were used for immunosuppression. After 1984, CsA was added 
to the immunosuppressive regimen. The overall patient survival 
rates have improved with each era (Fig 2). The one-year patient 
survival now is about 97%. 
The overall kidney graft survival rates also were stratified 
(Fig 3). The one-year kidney graft survival in the pre-CsA era 
was only 45%; now it exceeds 85%. 
Both the patient and kidney graft survival rates were better for 
patients with a living-related donor (LRD) as compared to a 
cadaver donor (Fig 4 to 7). The current one-year patient survival 
with an LRD is 100% versus 97% with a CAD. The current one-
year kidney graft survival with an LRD is 100% versus 84% with 
a CAD. 
The UNOS Scientific Renal Transplant Registry also pro-
vided data based on 41,240 renal transplants performed at 237 
U.S. transplant centers between October 1987 and November 
1992.8 These national statistics were compared to Hawaii's: The 
national overall one-year patient and kidney graft survival rates 
for cadaver transplants were 93% and 73%, respectively; com-
pared to our most recent results of95% and 85%, respectively. 
The UNOS Scientific Renal Transplant Registry also pro-
vided a "1991 Report of Center-Specific Graft and Patient 
Survival Rates" .9 This report was the first attempt to determine 
center-specific kidney transplant survival rates for all kidney 
transplant programs in the United States. In this report, UNOS 
provided graft and patient survival rates for patients whore-
ceived a kidney transplant from October 1, 1987 to December 
31, 1989. The report analyzed 19,990 kidney transplants per-
formed at 219 separate U.S. transplant programs during this 
time. In this report, our one-year patient survival of 93% and 
one-year graft survival of 83% were equivalent to or better than 
the UNOS national averages (Table 3). The results compare very 
favorably with those of larger centers in California. 
In 1993, 21 kidney transplants were performed in Hawaii: 17 
patients received cadaveric organs and 4 received organs from 
living-related donors. All of the patients have survived to date. 
Twenty of 21 patients currently have functioning grafts for an 
overall graft survival rate of95%. Stratifying the data based on 
organ source reveals that 100% of the LRD grafts are still 
functioning and 94% of the CAD organs (16/17) are still 
functioning. 
Discussion 
Since the first kidney transplant was performed in Hawaii, 
kidney transplantation has become the treatment of choice for 
-
selected patients with end-stage renal failure. As the sole trans-
plant center for Hawaii, St. Francis Medical Center continues to 
address the needs of patients with end-stage renal disease. In this 
retrospective review, the lessons learned over the past 25 years 
have been tremendous. This retrospective analysis will reflect 
past accomplishments, compare our current results with those of 
other centers in the country, and offer a glimpse into the future 
of kidney transplantation for patients in Hawaii. 
As the overall patient and graft survival rates have improved 
over the years, a milestone improvement seems to be that of 
better immunosuppression. The survival data improved dra-
matically after 1984 with the introduction of CsA. This new 
immunosuppressive regimen presumably allowed for a lower 
incidence of graft loss from rejection. Although not included in 
our data, during this period other centers have noted a lower 
incidence of infection from the lower use of nonspecific immu-
nosuppressive drugs such as prednisone and azathioprine. 7 This 
might help explain our improved one-year patient survival now 
at 96% and one-year graft survival now at 85%. Although it is 
not clear in the data, probably other factors contributed to this 
improvement including the increased experience of the trans-
plant team, improved ancillary support, better intensive care 
management, and newer antibiotics such as ganciclovir for 
treatment of severe CMV infections. 
The living-related donor kidney transplants continue to do 
much better than the cadaveric transplants in long-term graft 
survival. This is true in all other reports because a living-related 
donor allows for better HLA matching and shorter ischemic 
times, thereby avoiding preservation injury from acute tubular 
necrosis (ATN). 
Retrospective reviews and comparison reports are important 
both to show where we have been and where we could be headed 
in the future. Data from UNOS compiling national statistics and 
large center reports have been most helpful. 8•9 In the past, our 
program had been criticized for its geographic isolation and 
small size, and it was unfairly assumed that our results would not 
be as good as those of larger centers. However, our one-year 
patient survival is equivalent to the national average and our 
one-year kidney graft survival exceeds the national average. As 
compared to larger programs in California, our results clearly 
speak for themselves. This should be very reassuring to the 
people of Hawaii who rely on St. Francis Medical Center 
exclusively for their transplantation needs. 
Briefly, over the past 25 years, both hemodialysis and renal 
transplantation have advanced to the point where patients with 
end-stage renal disease can be managed with good long-term 
success rates. Recent data indicate that patient survival after 
transplantation is far superior to that of dialysis. In addition, 
kidney transplantation continues to be a more cost-effective 
treatment than dialysis. Perhaps more important, quality of life 
after successful transplantation is markedly better than dialysis. 
Thus, in 1994 all patients with end-stage renal disease should be 
considered as transplant candidates. The only absolute 
contraindications are active infection, active intravenous drug 
abuse, positive HIV status, and systemic malignancy. Relative 
contraindications include hepatitis, history of poor compliance 
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with medications, or advanced systemic diseases. As the techni-
cal aspects of renal transplantation have been perfected, patients 
in either age extreme or more advanced disease processes have 
been accepted as candidates. 
Preoperative evaluation.-An extensive evaluation of all 
patients referred for transplantation is performed, including a 
detailed history and physical exam, routine laboratory studies, 
chest radiograph, electrocardiogram, blood and human leuko-
cyte antigen (HLA) typing and viral serology. Certain candi-
dates might require more extensive preoperative evaluation 
such as diabetic patients or patients with potential cardiac and/ 
or pulmonary diseases. Patients older than 65 years constitute an 
increasingly larger group in the population in general and in 
those requiring dialysis or transplantation in particular. Careful 
evaluation of this group must be considered. Once a patient has 
been accepted for kidney transplantation, donor status is evalu-
ated. Living-related donors are preferred because of the im-
proved survival rates, ability to schedule cases electively, and 
the shortage of cadaver organs. If no living donor is available, 
patients are then placed on the cadaver donor waiting list. 
Perioperative care.-Current preservation techniques al-
low kidney storage for up to 72 hours with good success rates. 
Cold-storage time still is minimized, however, to reduce the 
incidence of delayed graft function. For this reason, once the 
cadaver kidney is procured, the recipient is admitted and trans-
planted as quickly as possible. HLA and blood typing of the 
donor are performed and preliminary cross matches are done 
Table 1 Patient Demographics 
Race 
Asian 
White 
Filipino 
Polynesian 
Black 
Hispanic 
ABO Blood Type 
0 
A 
B 
AB 
Data Unavailable 
Total 
Renal Disease 
Diabetes Mellitis 
Non-Diabetic 
Total 
Percent 
48.0 
30.0 
17.0 
4.1 
0.6 
0.3 
Number (Percent) 
141 (35.0) 
166 (41.0) 
64 (16.0) 
33 (8.0) 
2 (0.2) 
405(100.0) 
Number (Percent) 
37 (9.1) 
368 (90.9) 
405(100.0) 
using recipient serum. Once this matching is completed, the 
kidneys are assigned to the 2 recipients with a negative cross 
match and the highest number of points according to the alloca-
tion system developed by UNOS. This includes the degree of 
HLA antigen match, length of waiting time, and panel-reactive 
antibody (PRA). The recipient is admitted to the hospital on an 
urgent basis; chest radiograph, electrocardiogram, and routine 
preoperative laboratory tests are performed and a fmal crossrnatch 
is done. If needed, the recipient is dialyzed prior to surgery. 
Transplantation occurs within 12 to 24 hours of hospital admis-
sion. 
Operative procedure.-A central venous pressure monitor 
is routinely placed in all recipients in order to manage preoperative 
and postoperative fluids. A Foley catheter is inserted 
preoperatively and immunosuppressive medications and antibi-
otics are administered prior to the beginning of the actual 
surgery. The technical approach to kidney transplantation has 
remained the same since the procedure was first successfully 
performed in 1954. 
Briefly, a left or right lower-quadrant incision is made and the 
iliac vessels are dissected free extraperitoneally. The renal 
artery and vein from the donor kidney are anastamosed to the 
patient's iliac artery and vein, respectively. Revascularization is 
performed as quickly as possible to minimize ischemia time to 
the kidney. Before unclamping the revascularized kidney, the 
patient is fluid-resuscitated to maintain a systolic blood pressure 
of 140 rom Hg and central venous pressure to 12 rom Hg. 
Table 2 Causes of Renal Failure 
Primary Diagnosis 
Chronic Glomerulonephritis 
Diabetes Mellitus 
Systemic Lupus 
Polycystic Kidney 
Pyelonephritis 
Number (Percent) 
220 (51.3) 
40 (9.3) 
36 (8.4) 
22 (5.1) 
5 (1.2) 
Table 3 Overall Actual Survival Rates from 
Oct 1, 1987 to Dec 31,1989 
UNOS Hawaii CPMC* UCSF** 
Number of Kidney Transplants 
with Follow-up 19,588 54 344 521 
1-Year Graft Survival 
(Percent) 80 83 80 77 
Number of Kidney Transplants 
with Follow-up 18,930 54 342 518 
1-Year Patient Survival 
(Percent) 93 93 93 93 
• California Pacific Medical Center, San Francisco 
•• University of California, San Francisco 
-
HAWAII MEDICAL JOURNAL, VOL. 53, MARCH 1994 
66 
KIDNEY TRANSPLANTS IN HAWAII 
40 
35 1--
2 i 30 
~ ~ 25 ~ 
~ ~ 20 
il 
0 15 
In n ;~;;~ I 
W1 I~ 1.1 ••• II ll Ill Ill Ill II 
~ 
~ 10 
m 0 ~ ~ m 0 ~ ~ ~ ~ ~ 0 
~ ~ ~ ~ ~ ~ ~ ~ 
m ~ ~ ~ ~ ~ ~ ~ ~ ~ m ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ m m 
v .. , 
Figure 1.-A breakdown of 433 kidney transplants performed at St. Francis Medical 
Center by year and donor source. 
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Figure 3.-0verall graft survival rates for recipients of kidney transplants at St. Francis 
Medical Center. 
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Figure 5.-Patient survival rates for recipients with a cadaver donor kidney. 
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Figure 2. -Overall patient survival rates for recipients of kidney transplants at St. Francis 
Medical Center. The different eras include Pre CsA (1969 to 1983) and Post CsA 
(1984 to 1989 and 1990 to 1992). 
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Figure 4.-Patient survival rates for recipients with a living-related donor kidney 
transplant. 
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Figure 6.-Graft survival rates for recipients of a living-related donor kidney transplant. 
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Figure 7.-Graft survival rates for recipients of a cadaver kidney transplant. 
Furosemide (Lasix) and mannitol are administered as needed. 
The ureter is then implanted into the bladder via one of several 
techniques including the posterior Leadbetter-Politano or the 
Litch technique. 
Postoperative care.-All patients require support in the 
intensive care unit during the first 24 to 48 hours. Most patients 
are extubated immediately after completion of the procedure, 
the fluid and electrolyte status are carefully monitored, and the 
hourly urine output is recorded and rep laced cc for cc during the 
first 24 to 48 hours. After the first 24 hours, volume replacement 
is gradually decreased until maintenance replacement levels are 
reached. Patients with delayed graft function require special 
attention. Inadequate fluid resuscitation can result in acute 
tubular necrosis (ATN); overly aggressive fluid replacement 
can result in pulmonary edema or congestive heart failure. 
Medications.-Standard postoperative medications include 
immunosuppression; the current regimen includes prednisone, 
azathioprine (Imuran) and CsA in all patients. In addition, 
OKT3 or ATGAM immunotherapy can be used in cadaver 
recipients with delayed graft function. These drugs are standard 
and have been described elsewhere. Other standard medications 
include H2 blockers and trimethoprim-sulfamethoxazole 
(Bactrim) to prevent pneumocystis carinii and to decrease the 
incidence of urinary tract infection. Prophylactic antibiotics, 
CMV prophylaxis and occasionally fluconazol for fungal pro-
phylaxis are used for postoperative care. 
Early complications.-Delayed graft function from a pres-
ervation injury, ATN, or rejection can occur. A rapid diagnosis 
using ultrasound or renal scan needs to be done to rule out any 
technical problems. General complications might occur as with 
all other surgical procedures. Wound complication such as 
hematoma, seromas, and infections are of significant concern 
since these patients are immunosuppressed. Wound complica-
tion rates are less than 2%. The most devastating early postop-
erative complication is bleeding or thrombosis which can present 
with a sudden onset of anuria. Urologic complications including 
ureter disruption, urinary leaks and distal ureter stenosis with 
-
Kidney transplantation has evolved into a treatment of choice 
for selected patients with end-stage renal disease. With im-
provements in patient management, HLA matching, and immu-
nosuppressive protocols, the future of renal transplantation will 
include high risk groups such as the very young or the elderly. 
It is imperative that all patients with end-stage renal disease be 
given the option of kidney transplantation. As will be discussed 
later in this issue of the Journal, organ donation remains the 
major obstacle in kidney and solid organ transplantation. In 
Hawaii, there are more than 100 patients awaiting kidney 
transplant. All health professionals can make a difference by 
selecting and referring appropriate recipients and referring ap-
propriate donors. This gift of life must be available to the people 
of Hawaii. 
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